UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria

Pediatric blood & cancer, 2013-10, Vol.60 (10), p.1574-1581

2013

Link zum Volltext

Verfügbarkeit prüfen

Interdisciplinary care programme to improve self‐management for cancer patients undergoing stem cell transplantation: a prospective non‐randomised intervention study

European journal of cancer care, 2017-07, Vol.26 (4), p.e12458-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

S204: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONTLINE CHEMOTHERAPY: THE PHASE 2, OPEN‐LABEL, KEYNOTE‐667 STUDY

HemaSphere, 2022-06, Vol.6, p.105-106

2022

Link zum Volltext

Verfügbarkeit prüfen

A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY (R/R) SYSTEMIC ANAPLASTIC LARGE‐CELL LYMPHOMA (SALCL) OR R/R HODGKIN LYMPHOMA (HL)

Hematological oncology, 2017-06, Vol.35 (S2), p.248-249

2017

Link zum Volltext

Verfügbarkeit prüfen

Integrated information systems for translational medicine

Methods of information in medicine, 2007-01, Vol.46 (5), p.601

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular Mechanisms and Gene Regulation of Melphalan- and Hyperthermia-induced Apoptosis in Ewing Sarcoma Cells

Anticancer research, 2008-09, Vol.28 (5A), p.2585-2593

2008

Link zum Volltext

Verfügbarkeit prüfen

Heterozygous missense protein S mutation in a young boy with incomplete tetraplegia

Klinische Padiatrie, 2009-05, Vol.221 (3), p.180

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of interleukin-10 on phenotype and gene expression during early monocyte differentiation into dendritic cells

Anticancer research, 2013-11, Vol.33 (11), p.4791-4798

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II, open-label study of pembrolizumab in children and young adults with newly diagnosed classical Hodgkin lymphoma (cHL) with slow early response (SER) to frontline chemotherapy: KEYNOTE-667

Annals of oncology, 2019-11, Vol.30, p.ix96

2019

Link zum Volltext

Verfügbarkeit prüfen

Prevention of activated brown adipose tissue on 18F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trial

Scientific reports, 2023-12, Vol.13 (1), p.21944-21944, Article 21944

2023

Link zum Volltext

Verfügbarkeit prüfen

047 - PHASE 2 KEYNOTE-667 STUDY OF PEMBROLIZUMAB (PEMBRO) IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (Chl) AND SLOW EARLY RESPONSE (SER) TO FRONTLINE CHEMOTHERAPY (CHEMO)

Leukemia research, 2022-10, Vol.121, p.S33-S34

2022

Link zum Volltext

Verfügbarkeit prüfen

PHASE 2 KEYNOTE-667 STUDY OF PEMBROLIZUMAB (PEMBRO) IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (Chl) AND SLOW EARLY RESPONSE (SER) TO FRONTLINE CHEMOTHERAPY (CHEMO)

Leukemia research, 2022-10, Vol.121, p.S33-S34

2022

Link zum Volltext

Verfügbarkeit prüfen

PHASE 2 KEYNOTE‐667: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY

Hematological oncology, 2023-06, Vol.41 (S2), p.66-67

2023

Link zum Volltext

Verfügbarkeit prüfen

LUNG STAGING IN PEDIATRIC HODGKIN LYMPHOMA: STAGING EVALUATION & RESPONSE CRITERIA HARMONIZATION FOR CHILDHOOD, ADOLESCENT & YOUNG ADULT HL (SEARCH FOR CAYAHL) CONSENSUS

Hematological oncology, 2023-06, Vol.41 (S2), p.71-73

2023

Link zum Volltext

Verfügbarkeit prüfen

Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin's disease

Radiation oncology (London, England), 2019-09, Vol.14 (1), p.157-157, Article 157

2019

Link zum Volltext

Verfügbarkeit prüfen

Pediatric Nodular Lymphocyte-predominant Hodgkin Lymphoma: Treatment Recommendations of the GPOH-HD Study Group

Klinische Padiatrie, 2015-11, Vol.227 (6-7), p.314

2015

Link zum Volltext

Verfügbarkeit prüfen

Allo-SCT using BU, CY and melphalan for children with AML in second CR

Bone marrow transplantation (Basingstoke), 2013-05, Vol.48 (5), p.651-656

2013

Link zum Volltext

Verfügbarkeit prüfen

How to Overcome Scientific Standstill for Very Rare Diseases: Clinical Trials or Clinical Registries?

Klinische Padiatrie, 2015-11, Vol.227 (6-7), p.303

2015

Link zum Volltext

Verfügbarkeit prüfen

Challenges and Potential Solutions for Big Data Implementations in Developing Countries

Yearbook of medical informatics, 2014-08, Vol.23 (1), p.36-41

2014

Link zum Volltext

Verfügbarkeit prüfen

The EuroNet paediatric hodgkin network - modern imaging data management for real time central review in multicentre trials

Klinische Padiatrie, 2013-11, Vol.225 (6), p.357

2013

Link zum Volltext

Verfügbarkeit prüfen

High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity

Klinische Padiatrie, 2012-04, Vol.224 (3), p.156

2012

Link zum Volltext

Verfügbarkeit prüfen

Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy

Klinische Padiatrie, 2014-11, Vol.226 (6-7), p.307

2014

Link zum Volltext

Verfügbarkeit prüfen

FDG-PET in Hodgkin lymphoma

Nuclear medicine, 2008, Vol.47 (6), p.235

2008

Link zum Volltext

Verfügbarkeit prüfen

Early childhood intervention - access to risk families and support through actors from the health-care sector

Klinische Padiatrie, 2014-07, Vol.226 (4), p.243

2014

Link zum Volltext

Verfügbarkeit prüfen

Management of oncology patients admitted to the paediatric intensive care unit of a general children's hospital - a single center analysis

Klinische Padiatrie, 2011-05, Vol.223 (3), p.142

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(61)
Buchkapitel
(5)

Sprache

Englisch
(53)
Deutsch
(23)

Erscheinungsjahr

n.n

Thema

Humans
(38)
Science & Technology
(37)
Life Sciences & Biomedicine
(36)
Child
(19)
Pediatrics
(18)
Adolescent
(17)
Male
(17)
Female
(14)
Oncology
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Hematology
(8)
Child, Preschool
(7)
Hodgkin Disease - Pathology
(7)
Immunology
(7)
Original Article
(7)
Biological And Medical Sciences
(6)
Germany
(6)
Hodgkin Disease - Drug Therapy
(6)
Lymphoma
(6)
Medical Sciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria

Interdisciplinary care programme to improve self‐management for cancer patients undergoing stem cell transplantation: a prospective non‐randomised intervention study

S204: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONTLINE CHEMOTHERAPY: THE PHASE 2, OPEN‐LABEL, KEYNOTE‐667 STUDY

A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY (R/R) SYSTEMIC ANAPLASTIC LARGE‐CELL LYMPHOMA (SALCL) OR R/R HODGKIN LYMPHOMA (HL)

Integrated information systems for translational medicine

Molecular Mechanisms and Gene Regulation of Melphalan- and Hyperthermia-induced Apoptosis in Ewing Sarcoma Cells

Heterozygous missense protein S mutation in a young boy with incomplete tetraplegia

Impact of interleukin-10 on phenotype and gene expression during early monocyte differentiation into dendritic cells

Phase II, open-label study of pembrolizumab in children and young adults with newly diagnosed classical Hodgkin lymphoma (cHL) with slow early response (SER) to frontline chemotherapy: KEYNOTE-667

Prevention of activated brown adipose tissue on 18F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trial

047 - PHASE 2 KEYNOTE-667 STUDY OF PEMBROLIZUMAB (PEMBRO) IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (Chl) AND SLOW EARLY RESPONSE (SER) TO FRONTLINE CHEMOTHERAPY (CHEMO)

PHASE 2 KEYNOTE-667 STUDY OF PEMBROLIZUMAB (PEMBRO) IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (Chl) AND SLOW EARLY RESPONSE (SER) TO FRONTLINE CHEMOTHERAPY (CHEMO)

PHASE 2 KEYNOTE‐667: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY

LUNG STAGING IN PEDIATRIC HODGKIN LYMPHOMA: STAGING EVALUATION & RESPONSE CRITERIA HARMONIZATION FOR CHILDHOOD, ADOLESCENT & YOUNG ADULT HL (SEARCH FOR CAYAHL) CONSENSUS

Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin's disease

Pediatric Nodular Lymphocyte-predominant Hodgkin Lymphoma: Treatment Recommendations of the GPOH-HD Study Group

Allo-SCT using BU, CY and melphalan for children with AML in second CR

How to Overcome Scientific Standstill for Very Rare Diseases: Clinical Trials or Clinical Registries?

Challenges and Potential Solutions for Big Data Implementations in Developing Countries

The EuroNet paediatric hodgkin network - modern imaging data management for real time central review in multicentre trials

High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity

Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy

FDG-PET in Hodgkin lymphoma

Early childhood intervention - access to risk families and support through actors from the health-care sector

Management of oncology patients admitted to the paediatric intensive care unit of a general children's hospital - a single center analysis

Suchergebnisse filtern